Mercer Global Advisors
ORIC icon

Mercer Global Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

Mercer Global Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Buy
+9,387
New +$85.1K ﹤0.01% 3830

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIHC Capital Management Central $104M AUM
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return

Mercer Global Advisors's ORIC Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 9,387 shares worth $102K. The stake represents ﹤0.01% of the portfolio and ranks #3830 among its holdings.

163 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Mercer Global Advisors held 9,387 shares of Oric Pharmaceuticals worth $102K as of Q2 2026.
  • Oric Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3830 holding.
  • 163 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.